IV-361
IV-361 is a potent and selective CDK7 inhibitor with Ki ≤ 50 nM, exhibiting oral bioavailability. It demonstrates significant anti-tumor activity in preclinical cancer research, as evidenced in both cellular assays and in vivo models (US20190256531A1) .
Product Specifications
CAS Number
2055741-39-2
Field of Research
Cell Biology
Smiles
Cc1ccc (F) cc1NC (=O) N1Cc2c (NC (=O) C3 (CCC3) [Si] (C) (C) C) n[nH]c2C1 (C) C
Molecular Formula
C23H32FN5O2Si
Molecular Weight
457.625
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MAB764C 0.2 mL (200 µg)
CD16, Natural Killer Cells Antibody, Concentrate
Sign In for Pricing
View Details 
MBS1471855-01 0.5 mg (E-Coli)
Recombinant Tursiops truncatus Tumor necrosis factor (TNF), partial
Sign In for Pricing
View Details